Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Net Cash Flow: 2020-2024

Historic Net Cash Flow for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to -$465,258.

  • iSpecimen's Net Cash Flow rose 649.33% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 206.47%. This contributed to the annual value of -$465,258 for FY2024, which is 96.41% up from last year.
  • According to the latest figures from FY2024, iSpecimen's Net Cash Flow is -$465,258, which was up 96.41% from -$13.0 million recorded in FY2023.
  • Over the past 5 years, iSpecimen's Net Cash Flow peaked at $27.0 million during FY2021, and registered a low of -$13.0 million during FY2023.
  • Its 3-year average for Net Cash Flow is -$8.6 million, with a median of -$12.4 million in 2022.
  • In the last 5 years, iSpecimen's Net Cash Flow surged by 4,112.21% in 2021 and then slumped by 145.96% in 2022.
  • Yearly analysis of 5 years shows iSpecimen's Net Cash Flow stood at $642,016 in 2020, then skyrocketed by 4,112.21% to $27.0 million in 2021, then tumbled by 145.96% to -$12.4 million in 2022, then decreased by 4.30% to -$13.0 million in 2023, then soared by 96.41% to -$465,258 in 2024.